Dr. Mary Lynch, a pain researcher and head of the Canadian Consortium for the
Investigation of Cannabinoids in Human Therapeutics, says there is very little research to …

Dr. Mary Lynch, a pain researcher and head of the Canadian Consortium for the
Investigation of Cannabinoids in Human Therapeutics, says there is very little research to …

Abstract The new Health Canada regulations on medical marihuana would allow patients to
purchase dried cannabis from a licensed distributer with a medical prescription. Yet …

Science Base, said advances in cannabinoid science over the last 16 years offer
opportunities for the development of medical marijuana. The report summarizes and …

The hazy world of “medical marijuana” continues to cry out for clear data on which to base
medical decision making and rational policy design. In this issue of Clinical Pharmacology & …

In an article in this issue of the Journal, Hasin and colleagues (1) used data from the
National Epidemiologic Survey on Alcohol and Related Conditions to examine differences in …

In 1970, the Controlled Substances Act classified cannabis as a Schedule I drug; this
category is reserved for drugs that are defined as having “a high potential for abuse,”“no …

Approximately 156 million Americans (49% of the population) have tried cannabis.(1) About
5.7 million people ages 12 years and older use it daily or almost daily, a number that has …

Pain is the alarm of disease, the symptom that announces that all is not right with our bodies.
Whether due to accident or illness, it is the most common reason that people seek medical …

Despite accounts of medicinal marijuana dating back over 5000 years and references in the
medical literature emerging in the mid-1800s, public opinion on the medicinal use of …